sanofi-aventis U.S. has partnered with Rock Health to select seven esteemed individuals to judge the Innovation Challenge. These thought leaders are distinguished visionaries and practitioners in the areas of innovation, technology, data, healthcare, and government.
Rock Health is a seed accelerator targeting health-related mobile and web applications. By bringing together rich talent in technology and health, Rock Health provides funding, mentorship, and operational support to selected high-potential, early stage start-ups, nurturing the next-generation of the digital health ecosystem.
Jeff Hammerbacher is a founder and the Chief Scientist of Cloudera. Jeff was an Entrepreneur in Residence at Accel Partners immediately prior to founding Cloudera. Before Accel, he conceived, built, and led the Data team at Facebook. The Data team was responsible for driving many of the applications of statistics and machine learning at Facebook, as well as building out the infrastructure to support these tasks for massive data sets. The Data team produced open source projects such as Hive and Cassandra and their work was recognized at conferences such as CHI, ICWSM, SIGMOD, and VLDB. Before joining Facebook, Jeff was a quantitative analyst on Wall Street. Jeff earned his Bachelor's Degree in Mathematics from Harvard University and recently served as a Contributing Editor for O'Reilly's "Beautiful Data."www.cloudera.com
Manny is a nonprofit leader, a recognized social media author and consultant and a passionate diabetes advocate. He has 15+ years of experience in team management and project management and an extensive background in Web Product Development, Content Development and Community Management. In 2007, he co-founded TuDiabetes.org and EsTuDiabetes.org. As President of the Diabetes Hands Foundation (DHF), he’s been instrumental to the development of the DHF’s diabetes awareness programs and continued outreach to offer support and diabetes information to nearly 200,000 people touched by diabetes every month.www.tudiabetes.org
Hilary Mason is the Chief Scientist at bit.ly, where she finds sense in vast data sets. Her work involves both pure research and development of product-focused features. She’s also a co-founder of HackNY (hackny.org), a non-profit organization that connects talented student hackers from around the world with startups in NYC. Hilary recently started the data science blog Dataists (dataists.com) and is a member of hacker collective NYC Resistor. She has discovered two new species, loves to bake cookies, and asks way too many questions.bit.ly
Todd Park joined the U.S Department of Health and Human Services (HHS) as Chief Technology Officer in August 2009. In this role, he is responsible for helping HHS leadership harness the power of data, technology, and innovation to improve the health and welfare of the nation. Mr. Park co-founded Athenahealth in 1997 and co-led its development over the following decade into one of the most innovative, socially-oriented, and successful health information technology companies in the industry. Prior to Athenahealth, he served as a management consultant with Booz Allen & Hamilton, focusing on health care strategy, technology, and operations. Mr. Park has also served in a volunteer capacity as a senior health care advisor to Ashoka, a leading global incubator of social entrepreneurs, where he helped start a venture to bring affordable telehealth, drugs, diagnostics, and clean water to rural India. Mr. Park graduated magna cum laude and Phi Beta Kappa from Harvard College with an A.B. in economics.www.hhs.gov/open
Ms. Siegel is a general partner at MDV-Mohr Davidow Ventures and has spent more than two decades commercializing key enabling technologies in biomedical research and health care. Prior to joining MDV, Ms. Siegel was president and director of Affymetrix, Inc., a company that helped propel the expansion of the genomics field and the opportunity for personalized medicine. Formerly, Ms. Siegel was at Amersham International (now GE) where she held senior executive roles, including president of Hoefer-Pharmacia Biotech. She was also involved in commercializing key biomedical technologies at E. I. DuPont & Co., Eastman Kodak Co. and Bio-Rad Laboratories. Additionally, Ms. Siegel serves on the boards of Cellpoint Diagnostics, Pacific Biosciences and Raindance Technologies. Ms. Siegel received her B.S. in biology from the University of Puerto Rico and holds an M.S. in biochemistry and molecular biology from Boston University Medical School.www.mdv.com
Dr. Ida Sim is Professor of Medicine at UCSF, Director, UCSF Center for Clinical and Translational Informatics, and Co-Founder of OpenmHealth. She received her MD and her PhD in Medical Informatics from Stanford University. Dr. Sim’s research focus is on knowledge-based technologies for evidence-based practice, especially in the ontological representation of human studies for advancing clinical and translational research. She recently co-founded OpenmHealth, a new non-profit to create an open software architecture of shared analysis, data presentation, and evaluation modules to support systematic and shared learning to improve individual and population health through mobile and Internet technologies. In policy work, Dr. Sim was the founding Project Coordinator of the World Health Organization’s International Clinical Trials Registry Platform, which sets global standards on clinical trial registration and reporting. She is a recipient of United States Presidential Early Career Award for Scientists and Engineers (PECASE), and is a Fellow of the American College of Medical Informatics.http://openmHealth.org/
Dennis Urbaniak, VP U.S. Diabetes at sanofi-aventis, is a commercial operations executive with demonstrated leadership in driving innovative, customer centric approaches that result in tangible business results. Previous to his current position, Mr. Urbaniak was Vice President Innovation and New Customer Channels (INNCC). In this position, Mr. Urbaniak was responsible for exploring, testing and developing new business approaches and technologies to more effectively reach and understand our customers and deliver value. He worked cross-functionally with the Business Units, Marketing and a range of other departments to implement commercial innovations that reflect the evolving needs of our customer base.www.sanofi.us